I am a medicinal chemist with 8 years of experience in biotech. Prior to working in industry, I received my PhD in organic chemistry from Boston College and a BS in chemistry from Worcester Polytechnic Institute. I joined Entact Bio to be part of a highly collaborative team with the common goal of helping patients through the use of a novel approach to discovering medicines.
Outside of drug discovery, I enjoy spending time with my family, hiking throughout New England, and watching basketball.
Want to work with Tom?
See our latest job openingsGuiding a young, groundbreaking company to maturity calls for a leader who can strike the right balance between oversight and support. Victoria Richon is hoping to provide just that as the new CEO of Entact Bio, a preclinical biotech that came out of stealth in December...
The language of drug development is often militaristic. Medicinal chemists build arsenals of small molecules—looking for inhibitors or “warheads” that can hit “targets” and “combat” disease. Block, eliminate, disrupt, halt. For decades, drug makers have sought “magic bullets” that can precisely destroy ...
When proteins within the body get tagged with a molecule called ubiquitin, they are essentially marked for destruction. But they can be saved; a deubiquitinase enzyme can remove the ubiquitin, keeping the protein intact. That, at least in part, is what Entact Bio aims to do...
A small startup in Watertown has raised millions of dollars for early-stage research on a potentially powerful new idea that’s beginning to take hold in the biotech industry: designing drugs to enhance or prolong the function of helpful proteins that ward off disease. If successful, the approach could lead to new therapie...
Copyright © 2023
